Pan T - Cell Marker : CD 3

Yes. CD3 is a component of the T‑cell receptor complex expressed on essentially all mature T lymphocytes (including CD4+ helper and CD8+ cytotoxic subsets) and is used clinically as a pan‑T‑cell marker in flow cytometry and immunohistochemistry. It mediates TCR signal transduction. Rarely, very immature thymic precursors or certain leukemic cells show absent or aberrant CD3 expression.

CD3 positive means a T cell expresses the CD3 protein complex, part of the T‑cell receptor (TCR) that enables antigen recognition and signal transduction. CD3 is a pan‑T‑cell marker used in lab tests to identify and count mature T lymphocytes. Presence of CD3 indicates functional T cells; low or absent CD3 can point to T‑cell deficiency or developmental disorders.

A pan-T cell marker is a protein expressed on the surface of essentially all mature T lymphocytes, used to identify and quantify total T-cell populations by flow cytometry or immunohistochemistry. CD3 is the classic pan-T marker; CD2, CD5 and CD7 are also used. These markers confirm T‑cell lineage in diagnostics, monitor immune status, and help classify lymphoid malignancies.

A CD3 count measures T‑lymphocyte (T‑cell) levels by detecting the CD3 protein complex on their surface. In lymphoma, CD3 helps distinguish T‑cell from B‑cell disease, assess immune competence, and monitor treatment response or disease progression. Abnormally low or absent CD3 expression can indicate T‑cell depletion or certain T‑cell lymphomas; results are interpreted alongside other markers (e.g., CD4, CD8) and clinical findings.

CD3 positive means cells express CD3, a protein found on T lymphocytes, so CD3+ indicates T cells. CD20 positive means cells express CD20, a protein on B lymphocytes, so CD20+ indicates B cells. These markers are detected by flow cytometry or immunohistochemistry to identify and quantify lymphocyte types and help diagnose or classify immune disorders and lymphomas; results need clinical context.

A pan marker, often called pan‑cytokeratin, is an immunohistochemical antibody cocktail that broadly detects cytokeratin proteins in epithelial cells. Pathologists use it to identify epithelial‑origin tumors (carcinomas), highlight micrometastases, and distinguish epithelial lesions from non‑epithelial ones. It’s a screening tool that guides diagnosis but usually requires additional, more specific markers to determine exact tumor type.